UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PUSUANT TO SECTION 12(b) or (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
agilon health, inc.
(Exact name of registrant as specified in its charter)
Delaware | 37-1915147 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
agilon health, inc.
1 World Trade Center, Suite 2000
Long Beach, CA 90831
(Address of principal executive offices)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered |
Name of each exchange on which each class is to be registered |
|
Common Stock, par value $0.01 per share | New York Stock Exchange LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement or Regulation A offering statement file number to which this form relates (if applicable): 333-254435
Securities to be registered pursuant to Section 12(g) of the Act:
None
Item 1. Description of Registrants Securities to be Registered
A description of the registrants Common Stock, par value $0.01 per share (the Common Stock), is set forth under the caption Description of Capital Stock in the registrants registration statement on Form S-1 (File No. 333-254435) filed with the Securities and Exchange Commission on March 18, 2021, as thereafter amended (the Registration Statement), which is incorporated herein by reference. The form of prospectus that constitutes part of the Registration Statement and is filed by the registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed incorporated herein by reference.
Item 2. Exhibits.
List below all exhibits filed as a part of the registration statement:
Under the instruction as to exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the registrant are registered with the New York Stock Exchange LLC and the Common Stock registered hereby is not being registered pursuant to Section 12(g) of the Exchange Act of 1934, as amended.
2
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
agilon health, inc. |
||
By: |
/s/ Theodore Halkias |
|
Name: |
Theodore Halkias |
|
Title: |
Chief Business Officer |
Date: April 14, 2021
3